Retrospective population‐based analysis of the dose‐response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

Clinical Pharmacology & Therapeutics

Volumn 56, Issue 1, 1994, Pages 82-85

  Zhi, J ^a   Melia, A T ^a   Guerciolini, R ^a   Chung, J ^a   Kinberg, J ^a   Hauptman, J B ^a   Patel, I H ^a  

^a Pharma Research and Early Development Oncology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; PLACEBO; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FECES; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID ABSORPTION; MALE; MULTICENTER STUDY; OBESITY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; LACTONES; LIPASE; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 0028103894     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1994.104     Document Type: Article

References (0)